Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
2.960
+0.240 (8.82%)
At close: May 12, 2025, 4:00 PM
2.840
-0.120 (-4.05%)
After-hours: May 12, 2025, 6:34 PM EDT
Atea Pharmaceuticals Market Cap
Atea Pharmaceuticals has a market cap or net worth of $253.32 million as of May 12, 2025. Its market cap has decreased by -18.66% in one year.
Market Cap
253.32M
Enterprise Value
-199.76M
1-Year Change
-18.66%
Ranking
Category
Stock Price
$2.96
Market Cap Chart
Since the IPO on October 30, 2020, Atea Pharmaceuticals's market cap has decreased from $1.94B to $253.32M, a decrease of -86.93%. That is a compound annual growth rate of -36.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 232.78M | -17.73% |
| Dec 31, 2024 | 282.95M | 11.19% |
| Dec 29, 2023 | 254.48M | -36.48% |
| Dec 30, 2022 | 400.61M | -46.08% |
| Dec 31, 2021 | 742.94M | -78.48% |
| Dec 31, 2020 | 3.45B | 78.13% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |